Group 1 - The company announced the resignation of its Deputy General Manager, Ms. Kong Xiaoxia, due to internal adjustments, with her original term set to end on May 19, 2027 [2] - The company held its 10th meeting of the 4th Board of Directors on February 5, 2026, where it approved the appointment of Ms. Wang Si as the new Deputy General Manager and Board Secretary [2] - Following her appointment, Ms. Wang Si will no longer serve as the company's Securities Affairs Representative, and the current Chairman and General Manager, Mr. Liu Yang, will cease to act as the Board Secretary [2] Group 2 - Ms. Wu Yang has been appointed as the new Securities Affairs Representative, with her term starting from the date of the board's approval until the end of the current board's term [2]
维康药业：关于副总经理辞职及聘任副总经理、董事会秘书和证券事务代表的公告